We are pleased to report the successful presentation of the TOFU (Treating Ocular Inflammation and Uveitis) Registry at the 2026 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Denver, Colorado.
ARVO represents the global epicenter for translational vision science and ophthalmic research, convening international experts to advance the prevention, diagnosis, and treatment of visual system disorders.
The TOFU registry functions as a prospective, multicenter registry dedicated to the systematic generation of longitudinal real-world evidence (RWE) in non-infectious uveitis. By capturing real-world clinical trajectories, treatment patterns, and therapeutic outcomes across diverse patient cohorts, the registry addresses critical evidence gaps in ocular inflammatory disease management.
Presenting our ongoing collaborative initiative at ARVO 2026 reinforces the registry's role in advancing precision medicine and establishing evidence-based standards in uveitis care. We express our sincere gratitude to all clinical investigators and participating institutions whose rigorous data contribution continues to drive this international research effort.
The presentation was given by Dr. David Fink based on a poster. The corresponding abstract can be found at the following link.
